Dublin, June 22, 2017 (GLOBE NEWSWIRE) — Research and Markets has announced the addition of the “Point-of-Care Diagnostics Global Market – Forecast to 2023” report to their offering.
The point of care diagnostics global market is expected to grow at single digit CAGR to reach $26,331.1 million by 2023.
Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time. It can be performed by non-laboratory personnel and the main benefit of POCT is to make tests more convenient and immediately to the patient that helps doctors/physician to receive the results quicker, enabling clinicians to support the timely diagnosis, monitoring, and treatment of patients. It can be performed by non-laboratory personnel and the results are used for clinical decision making.
POCD is usually used in clinics, healthcare departments, hospitals, and patient’s homes. In hospitals, they are primarily performed in emergency departments, surgical suites, critical care units, and certain outpatient areas. POC tests can be performed by a wide variety of people can, including laboratory professionals, emergency first responders, radiologists, doctors, nurses, physician assistants, or other healthcare practitioners.
They may even be done by patients, sometimes called “self-tests” or “home tests. POCT has a range of complexity and procedures that vary from manual methodologies to automated analyzers. With the advancements in technology, POC testing analyzers are becoming smaller, faster, and more user-friendly and to achieve accuracy with increasingly smaller samples (body fluids).
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.4 Market Dynamics
3.4.1 Drivers and Opportunities
3.4.1.1 Rapid Rise in the Aging Population
3.4.1.2 High Prevalence of Chronic and Infectious Diseases
3.4.1.3 Lack of Skilled Laboratory Technicians in Emerging Countries
3.4.1.4 Rising Number of Clia-Waived Poc Tests
3.4.1.5 Rising Awareness About Point of Care Diagnostics in Developing Countries
3.4.1.6 Technological Advancements
3.4.2 Restraints and Threats
3.4.2.1 Inconsistent Reimbursement and High Cost of Devices
3.4.2.2 Stringent Regulatory Requirements
3.4.2.3 Rising Incidence of Product Recalls
3.4.2.4 Accuracy Issues
3.5 Regulatory Affairs
3.6 Porter’s Five Force Analysis
3.7 Market Share Analysis
3.8 Technological Advancements
3.9 Funding Scenario
3.10 Supply Chain Analysis
4 Point of Care Diagnostics Global Market, by Products
4.1 Introduction
4.2 Glucose Monitoring Kits
4.3 Infectious Diseases Testing Kits
4.4 Coagulation Monitoring Kits
4.5 Hematology Testing Kits
4.6 Pregnancy and Fertility Testing Kits
4.7 Cardiometabolic Monitoring Kits
4.8 Tumor/Cancer Markers
4.9 Urinalysis
4.10 Cholesterol Testing Kits
4.11 Drugs-Of-Abuse Testing Kits
4.12 Others
4.13 Genetic Markers/Testing Kits
4.14 Faecal Occult Blood Testing Kits
5 Point of Care Diagnostics Market, by Technology
5.1 Introduction
5.2 Biosensor Technology
5.3 Immunochromatographic/Lateral Flow Technology
5.4 Polymerase Chain Reaction(PCR) Technology
5.5 Microfluidic/Lab-On-A-Chip Technology
5.6 Other Technologies
6 Point of Care Diagnostics Market, by Prescription Mode
6.1 Introduction
6.1.1 Prescription Based Testing Kits
6.1.2 Over the Counter(OTC) Testing Kits Market
7 Point of Care Diagnostics Market, by Sample Type
7.1 Introduction
7.1.1 Blood
7.1.2 Urine
7.1.3 Saliva
7.1.4 Other
8 Point of Care Diagnostics Global Market, by End User
8.1 Introduction
8.2 Clinics
8.3 Hospitals
8.4 Home Healthcare
8.5 Other End-Users
9 Regional Market Analysis
10 Company Developments
11 Major Companies
- Abbott Laboratories, Inc
- Ascensia Diabetes Care Holdings Ag.
- Becton Dickinson and Company
- Biomerieux
- Danaher Corporation
- F.Hoffmann-La Roche Holdings Ag
- Johnson & Johnson
- Medtronic Plc
- Nova Biomedical
- Siemens Ag
- Thermofisher Scientific Inc.
Companies Mentioned
- A. Menarini Diagnostics S.R.L
- Abaxis, Inc.,
- Abbott Laboratories, Inc.
- Accriva Diagnostics
- Accurex Biomedical
- Accutech Inc
- Acon Laboratories, Inc
- Adaltis
- Alfa Scientific Designs
- Ani Biotech Oy,
- Aquila Diagnostics Inc.
- Arborvita
- Arkray, Inc
- Ascensia Diabetes Care Holdings Ag
- Atlas Genetics
- Atomo Diagnostics
- Beacon Biomedical
- Becton Dickinson and Company
- Bio-AMD
- Biolight Life Sciences
- Biolytical Laboratories Inc.
- Biomedica
- Biomerieux
- BTNX Inc
- Cardinal Health
- Chembio Diagnostic Systems, Inc.
- Church & Dwight Co., Inc.,
- Coeliac Australia
- Curiosity Diagnostics
- Daktari Diagnostics
- Danaher Corporation
- DCC Plc.,
- Dexcom Inc.
- Diabetomics
- Diasys Diagonstics Systems, Gmbh
- EFK Diagnostics
- Elitechgroup Molecular Diagnostics
- Enigma Diagnostics
- Enterix, Inc
- Epitope Diagnostics Inc,
- Erba Diagnostics Mannheim Gmbh
- Euromedix Poc NV/SA
- Exosomes Diagnostics
- F. Hoffmann-La Roche Ag
- Fannin
- First Diagnostics Corporation
- Glysens, Inc.
- Glysure
- Helena Laboratories
- Hemosure Inc.,
- Horiba
- Humor Diagnostica
- Inbios
- Insilixa, Inc
- Instrumentation Laboratories
- International Biomedical
- International Technidyne Corporation(Itc)
- Ioniconanalytik Gmbh
- Johnson & Johnson (J&J)
- Kamineni Lifescience
- KMC Systems
- Koroglu Medical Devices Ltd
- Labsystems Diagnostics OY
- Labtician Ophthalmics, Inc
- Lifescan
- Lipid Plus
- Mbio Diagnostics, Inc
- Medica Corporation
- Medmira Inc.
- Medtronic Plc
- Meridian Bioscience, Inc,
- Mindray
- Nanoentek
- Nanorepro
- Nanospeed Diagnostics
- Nemaura Medical
- Ngaio Diagnostics
- Nipro Diagnostics
- Nova Biomedical
- Novamax
- Nowdiagnostics
- Oasis Diagnostics
- Omega Diagnostics
- Omnica Corporation
- Oncogenesis
- Operon Biotech & Healthcare
- Ophthalmic Instrument Company
- OPKO Diagnostics
- Optiscan
- Orasure Technologies, Inc.
- Perkin Elmer
- Phoenix Medcare
- POC Medical Systems, Inc.,
- Polymer Technology Systems, Inc
- Premier Medical Corporation Ltd.
- Prestige Brands Holdings, Inc.,
- Probe Scientific
- Prodigy
- PTS Diagnostics
- Quidel Corporation
- Response Biomedical
- Rps Diagnostics
- Senseonics
- Siemens Ag
- Simple Diagnostics
- Skannex As
- Sorrento Therapeutics
- Sugentech Inc.
- Swiss Precision Diagnostics GmbH
- Sysmex Corporation
- Tb Biosciences, Inc
- Tel-Array
- Terumo Corporation
- Thermofisher Scientific, Inc.
- Transasia Bio-Medicals
- Trinity Biotech
- Trivitron Healthcare
- Universal Biosensors
- US Diagnostics
- ZBX Corporation
For more information about this report visit https://www.researchandmarkets.com/research/f42lnz/pointofcare
CONTACT:
CONTACT: Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Point-of-Care Diagnostics
